Nutricia, the New Zealand infant formula unit of French food maker Danone, posted a 97 per cent drop in profit in 2013, a year that saw sales disrupted by Fonterra's false alarm botulism scare last August.
Profit fell to $1.99 million in the year ended December 31, from $61.1 million a year earlier, according to the company's financial statements lodged with the Companies Office. Sales fell 15 per cent to $318.2 million while cost of sales rose 8.1 per cent to $265 million.
Globally, Danone's early life nutrition unit reported annual revenue growth of 0.1 per cent to 4.26 million euro, as a 13 per cent drop in second-half sales offset a 14 per cent gain in the first half.
Infant formula sales for Danone's Nutricia unit plunged last August as it recalled infant formula from New Zealand, China, Singapore, Malaysia, Hong Kong, Vietnam, Cambodia and Thailand after Fonterra quarantined several batches of whey protein concentrate on fear it was contaminated with a potentially dangerous strain of clostridium bacteria, capable of causing botulism. The strain was ultimately shown to be harmless.
"The botulism scare caused serious damage to Danone Nutricia's business," which was reflected in global sales, a spokeswoman for Danone said in an email to BusinessDesk, declining to make any specific comment on the New Zealand unit.